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Background: Door-to-balloon times strongly correlate with survival in patients referred
for primary PCI. Guidelines have recommended that regions develop STEMI systems that
quickly triage patients for primary PCI. We sought to evaluate door-to-balloon time
amongst patients referred for primary PCI according to different referral pathways in the
province of Ontario.
Methods: We used the provincial primary PCI registry database developed by the
Cardiac Care Network of Ontario Cath/PCI Working Group. We identified all patients
who underwent primary PCI between July 2009 and December 2011 at 14 PCI capable
centers. We evaluated time to reperfusion according to the following referral pathways: i)
Field directly to the PCI center catheterization laboratory; ii) Field to the PCI center
emergency department (ED); iii) Field to a non-PCI center ED; iv) Self-transport (Self-T)
to a PCI capable center ED; v) Self-T to a non-PCI capable center ED. We excluded
in-hospital patients presenting with STEMI on the wards. The primary endpoint was the
first hospital door-to-balloon-time.
Results: 6198 patients were referred for primary PCI. PCI was performed in 5678
patients. Data was available to calculate door-to-balloon times in 4763 patients. Amongst
these patients, 63% were transported initially from the field, and 37% self-transported to
the ED. The median door-to-balloon time with interquartile range for each referral
pathway is shown in the table. Patients referred directly to the cath lab had significantly
faster door-to-balloon times.
Door-to-balloon time (minutes)
Time
Field to PCI
center cath
lab
Field to PCI
center ED
Field to
non-PCI
center
Self-T to
PCI
center
ED
Self-T to
non-PCI
center
ED
P value>N1310 N717 N 970 N510 N1256
Median 46 80 122 104 120 0.0001
IQR 34-63 58-111 95-184 77-146 97-171
Conclusions: Prehospital triage is associated with very short door-to-balloon times when
patients are transported directly to the catheterization laboratory. Self-transport leads to
shorter door-to-balloon time when the pt presents at a PCI center. These results are
relevant to regions planning to develop STEMI systems.
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Background: The effect of multi-vessel disease (MVD) with or without a concomitant
coronary chronic total occlusion (CTO) has never been investigated in patients treated
with rescue percutaneous coronary intervention (PCI). This study evaluates whether there
is an increased rate of death at 1-year follow-up in patients undergoing rescue PCI with
angiographic pattern of MVD and a concurrent CTO in comparison with single vessel
disease (SVD) and MVD without CTO.
Methods: Among 551 consecutive patients undergoing rescue PCI, we compared the
1-year survival rates of 361 patients with SVD, 137 with MVD without a CTO and 53
with MVD and a CTO.
Results: Patients with MVD were older than SVD (62	10 vs 57	11 yrs, p0.001) and
more often admitted with cardiogenic shock (14% vs 3% p0.001). Patients with MVD
and CTO had more often previous myocardial infarction (19% vs 4% vs 4%, p0.001),
lower ejection fraction (42	11% vs 47	11% vs 49	11%) and longer pain to PCI time
(8	6 vs 7	5 vs 7	5 hours, p0.001) compared with patients with SVD and MVD
without CTO, respectively. The 1-year mortality rates of patients with SVD, MVD
without CTO and MVD with CTO were 5%, 13% and 27% respectively (P0.001). The
Cox proportional hazard model identified the presence of MVD with CTO as a strong
predictor of death at 1-year follow-up (HR: 3.4, 95% CI: 1.6 to 7.1, p0.001) while MVD
alone did not result as a predictor of outcome (HR: 1.9, 95% CI: 0.9 to 3.8, p0.064).
Adjusted 1-year overall survival rates were 96%, 91.4% and 83.4%, (p0.001) in the
groups with SVD, MVD without and with CTO, respectively.
Conclusions: Patients with MVD and concurrent CTO have higher mortality rates than
those with SVD or MVD without CTO at 1-year follow-up after rescue PCI. MVD with
CTO and not MVD alone is a predictor of death at 1-year follow up.
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Background: Rates of stent thrombosis (ST) may vary overtime and the relationship of
this complication with non-adherence to dual antiplatelet therapy (DAPT) during
long-term follow-up remains unclear.
Methods: We analyzed 2,997 patients who were treated with at least 1 stent and in whom
a non-target vessel ST did not occur during follow-up from the large-scale HORIZONS-
AMI trial of patients with STEMI undergoing primary PCI. Aspirin was prescribed
indefinitely, and a theinopyridine for at least 6 months. DAPT usage was evaluated
according to the development of ST in 4 time periods (1 month, 1-6 months, 6-12
months and 1 year from index stent implantation).
Results: Rates of ST and DAPT usage are shown in the Table. DAPT non-usage was
lowest within the first month, and we observed no relationship between confirmed
discontinuation of antiplatet therapy and stent thrombosis during the first month. During
the 1-6 month period we observed a clear relationship between non-usage of DAPT and
definite/probable ST. However, this relationship was absent in the 6-12 month period.
Beyond one year, ST was associated with non-usage of aspirin but was paradoxically
more common in patients taking a thienopyridine.
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